Pillar · Biotech Investing
Biotech Due Diligence Checklist: How to Evaluate a Drug Pipeline and Probability of Approval
Most biotech investors skip due diligence and pay the price. This step-by-step checklist walks you through everything yo...
Start here
Pillar · Clinical Readouts
How to Read Biotech Clinical Trial Data: Phase 1, 2, 3 Results Explained for Investors
Clinical trial data is the single most important factor in biotech investing, but most investors struggle to read it. Th...
FDA & PDUFA Calendar
Biotech Catalysts Q3 2026: Key Developments and Upcoming Opportunities
As of Q3 2026, we analyze crucial biotech catalysts, including Ameluz®PDT and zervimesine, and their potential impact on market dynamics....
FDA & PDUFA Calendar
Ameluz PDT and Zervimesine: Biotech Catalysts July
Discover the top biotech catalysts to watch in July 2026, including Ameluz for sBCC and zervimesine for DLB psychosis....
Clinical Readouts
Cognition CT1812 Alzheimer's: Phase 3 Readouts 2026
As we approach pivotal phase 3 readouts, we analyze key clinical trial results and their potential impact on biotech investments....
FDA & PDUFA Calendar
FDA Calendar July 2026: Key PDUFA Dates and Upcoming Approvals
July 2026 brings critical PDUFA dates, including Relacorilant and FUROSCIX ReadyFlow. Get insights on approval probabilities and market implications....
Catalyst Analysis
Biotech Catalyst Trading: How Hedge Funds and Insiders Position Around FDA Decisions
The biggest moves in biotech happen around catalysts like PDUFA dates and data readouts. This guide reveals how top hedge funds like Baker Brothers and OrbiMed ...
Biotech Investing
How to Invest in Biotech Stocks: Beginner Guide to FDA Approvals, Clinical Trials and PDUFA Dates
Biotech investing is not like any other sector. A single FDA approval can send a stock up 100% overnight and a failed trial can wipe out 70% of a company's valu...
Biotech Investing
Respiratory Biotech Investing: Key Clinical Catalysts and Investor Outlook
Respiratory biotech stocks often surge on pivotal trial data or FDA approvals. Explore benchmarks, case studies, and investor strategies for this sector....
Biotech Investing
Cardiovascular Biotech Investing: High-Impact Catalysts and Market Insights
Cardiovascular biotech stocks often move on large outcomes trials or niche breakthroughs. Explore benchmarks, case studies, and strategies for investors....
Biotech Investing
Neurology Biotech Investing: Key FDA Catalysts & Investor Strategies
Explore how biotech catalysts in neurology create major opportunities for investors. Learn key benchmarks, case studies, and investing strategies....